5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000276:immunology; D000328:Adult; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000276:immunology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage*
D002272:Carcinoembryonic Antigen; D008937:Mitomycins; D005472:Fluorouracil; D008727:Methotrexate